Explore 3 Stock Ideas & Industry Insights Download Free Report

Grown Rogue International Inc

Healthcare CA GRIN

0.62CAD
0.02(3.33%)

Last update at 2026-06-22T15:26:00Z

Day Range

0.600.62
LowHigh

52 Week Range

0.380.72
LowHigh

Fundamentals

  • Previous Close 0.60
  • Market Cap117.47M
  • Volume1000
  • P/E Ratio23.50
  • Dividend Yield-%
  • EBITDA0.11M
  • Revenue TTM32.43M
  • Revenue Per Share TTM0.13
  • Gross Profit TTM 13.83M
  • Diluted EPS TTM0.02

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-10-31 2024-10-31 2023-10-31 2022-10-31 2021-10-31
Type yearly yearly yearly yearly yearly
Date 2025-10-31 2024-10-31 2023-10-31 2022-10-31 2021-10-31
Income before tax 4.83M -9.00097M -0.29139M 0.67M -0.86420M
Minority interest -1.50015M -0.60685M 0.13M 0.03M -1.39556M
Net income 1.73M -11.30364M -0.53304M 0.45M -1.01475M
Selling general administrative 11.44M 11.38M 6.81M 5.92M 4.26M
Selling and marketing expenses - - - - -
Gross profit 14.15M 13.98M 11.89M 8.12M 6.10M
Reconciled depreciation 2.84M 2.92M 2.34M 1.85M 0.92M
Ebit - - - 1.45M 1.63M
Ebitda - - - 3.30M 2.55M
Depreciation and amortization - - - 1.85M 0.92M
Non operating income net other - - - - -
Operating income 2.00M 1.12M 4.25M 1.45M 1.63M
Other operating expenses - - - 16.31M 7.73M
Interest expense 1.38M 2.42M 1.03M 0.89M 1.15M
Tax provision - 1.70M 0.37M 0.25M 0.15M
Interest income 0.18M 12.27M 4.81M 0.74M 1.49M
Net interest income -3.79811M -4.28142M -3.35804M -0.89402M -1.14744M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - 0.25M 0.15M
Total revenue 32.43M 27.02M 23.35M 17.76M 9.38M
Total operating expenses 30.43M 24.04M 16.11M 6.67M 4.45M
Cost of revenue 18.28M 13.03M 11.46M 9.63M 3.28M
Total other income expense net 6.63M -7.69919M -4.17492M -0.78019M -2.49852M
Discontinued operations - - - - -
Net income from continuing ops 4.83M -10.69679M -0.66232M 0.42M -1.01475M
Net income applicable to common shares - -11.30364M -0.53304M 0.45M -2.41031M
Preferred stock and other adjustments - - - - -
Breakdown 2025-10-31 2024-10-31 2023-10-31 2022-10-31 2021-10-31
Type yearly yearly yearly yearly yearly
Date 2025-10-31 2024-10-31 2023-10-31 2022-10-31 2021-10-31
Total assets 62.74M 43.32M 30.16M 16.37M 14.21M
Intangible assets 3.03M 1.26M 0.73M 0.48M 0.15M
Earning assets - - - - -
Other current assets - 0.86M 0.39M 0.35M 0.36M
Total liab 38.82M 28.76M 17.61M 7.43M 7.09M
Total stockholder equity 20.90M 14.55M 11.56M 6.93M 5.09M
Deferred long term liab - - - - -
Other current liab 0.14M 12.50M 7.81M 0.67M 0.63M
Common stock - 38.50M 24.59M 21.86M 20.50M
Capital stock 62.59M 38.50M 24.54M 21.86M 20.50M
Retained earnings -41.56395M -32.84733M -20.99645M -21.35689M -21.80435M
Other liab - - - - 0.12M
Good will - - - 0.25M 0.25M
Other assets - 5.11M 2.01M - -
Cash 11.37M 4.68M 8.86M 1.58M 1.11M
Cash and equivalents - 4.68M 6.80M - -
Total current liabilities 5.72M 19.97M 13.00M 5.32M 3.86M
Current deferred revenue - - - 0.03M -
Net debt 1.22M - - 3.33M 3.46M
Short term debt - 0.00000M 0.00000M 2.79M 1.47M
Short long term debt 2.58M 2.17M 1.29M 1.77M 0.84M
Short long term debt total - - - 4.91M 4.57M
Other stockholder equity - -0.12593M -0.10807M 6.54M 6.48M
Property plant equipment - 11.87M 8.82M 7.73M 5.74M
Total current assets 22.18M 20.66M 17.42M 7.91M 6.71M
Long term investments 1.36M 1.81M 0.00000M 0.00000M 1.36M
Net tangible assets - - - 6.21M 4.69M
Short term investments - - - - -
Net receivables 3.65M 1.60M 2.01M 1.64M 0.74M
Long term debt 10.02M 1.00M 2.52M 0.84M 1.37M
Inventory 7.08M 6.32M 6.06M 4.33M 4.49M
Accounts payable 1.26M 2.11M 2.36M 1.82M 1.77M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - -0.10961M -0.09038M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.30M - - - -
Deferred long term asset charges - - - - -
Non current assets total 40.56M 21.13M 12.74M 8.46M 7.50M
Capital lease obligations 14.08M 5.21M 2.92M 2.30M 2.36M
Long term debt total - 5.48M 4.51M 2.11M 3.10M
Breakdown 2025-10-31 2024-10-31 2023-10-31 2022-10-31 2021-10-31
Type yearly yearly yearly yearly yearly
Date 2025-10-31 2024-10-31 2023-10-31 2022-10-31 2021-10-31
Investments - -12.19801M -2.88731M -1.11328M -0.75000M
Change to liabilities - - - -0.21972M -0.29485M
Total cashflows from investing activities - -12.19801M -2.88731M -1.11328M -2.72701M
Net borrowings 10.08M -2.72680M 4.43M -1.72254M -1.07598M
Total cash from financing activities 9.75M 2.95M 4.43M -0.42254M 3.86M
Change to operating activities - - - -0.00848M -0.20237M
Net income 1.73M -10.69679M -0.66232M 0.42M -1.01475M
Change in cash 6.45M -2.12236M 7.28M 0.47M 0.90M
Begin period cash flow 4.92M 6.80M 1.58M 1.11M 0.22M
End period cash flow 11.37M 4.68M 8.86M 1.58M 1.11M
Total cash from operating activities 3.57M 7.12M 5.73M 2.00M -0.23846M
Issuance of capital stock 0.00000M 0.00000M 0.00000M 1.30M 4.96M
Depreciation 2.84M 0.94M 0.58M 1.85M 0.92M
Other cashflows from investing activities - -10.45900M -1.43053M -0.00200M -0.67987M
Dividends paid - - - - -
Change to inventory 1.00M -0.19284M -0.76764M -0.09539M -1.35957M
Change to account receivables -1.35115M 0.05M -0.46547M -0.90471M -0.41206M
Sale purchase of stock - 5.02M 0.00000M 1.30M 4.96M
Other cashflows from financing activities - 0.66M - 0.10M 1.10M
Change to netincome - - - 1.98M 4.12M
Capital expenditures 4.66M 1.74M 1.46M 1.11M 2.05M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.01M 1.39M -0.67716M -1.17111M -2.13171M
Stock based compensation 2.39M 1.31M 0.34M 0.12M 0.41M
Other non cash items 1.62M 2.58M 0.24M 0.78M 0.27M
Free cash flow -1.08921M 5.39M 4.27M 0.89M -2.28560M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
GRIN
Grown Rogue International Inc
0.02 3.33% 0.62 23.50 - 3.62 4.10 3.13 11.19
GTII
Green Thumb Industries Inc
-0.15 1.40% 10.60 14.70 34.84 1.91 0.86 1.61 3.95
CL
Cresco Labs Inc
-0.07 6.09% 1.08 - 105.26 0.70 0.99 1.32 42.44
JUSH
Jushi Holdings Inc
-0.01 1.49% 0.66 - 17.86 0.52 0.69 1.41 9.56
AAWH-U
Ascend Wellness Holdings Inc.
-0.04 7.69% 0.48 - 10.88 0.22 59.95 1.23 7.98

Reports Covered

Stock Research & News

Profile

Grown Rogue International Inc., a craft cannabis company, focuses on premium flower and flower-derived products. It produces a range of cultivars for consumers, which are classified as indicas, sativas, and hybrids. The company sells its products through dispensaries. Grown Rogue International Inc. was incorporated in 1978 and is headquartered in Medford, Oregon.

Grown Rogue International Inc

550 Airport Road, Medford, OR, United States, 97504

Key Executives

Name Title Year Born
Mr. J. Obie Strickler President, CEO & Chairman 1981
Mr. Andrew Marchington CPA CFO & Corporate Secretary NA
Nolan Snyder National Director of Sales NA
Mr. David Pleitner Manager of Golden Harvests NA
Jakob Iotte Director of Business Development & IR NA
Mr. Joshua Nathaniel Rosen Chief Strategy Officer 1974
Ms. Kala Bernhardt Corporate Controller NA
Mr. J. Obie Strickler President, CEO & Chairman 1982

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions